Kudos to the folks who raised a ruckus this week about the fact that the DEA had not yet removed the reference to American Medical Association’s support for marijuana being in Schedule 1. With the AMA’s turnaround last week, it was unlikely that the DEA would actually, uh, mention the AMA’s call for a schedule change, but it certainly made sense to get the old info cleared off.
It’s gone now. Which, if you read the changed page, is kind of like removing one maggot from a large sack of feces.
So CNN paid 8 million dollars to make Lou Dobbs go away. Could be money well spent. However, if they wanted me to stay away from CNN, I’d do it for half that. Maybe less.
I’m all for gender equality, but… not this way.
As drug violence seeps deeper into Mexican society, women are taking a more hands-on role.
In growing numbers, they are being recruited into the ranks of drug smugglers, dealers and foot soldiers. And in growing numbers, they are being jailed and killed for their efforts.
This is from a while ago â€” it got lost on my desktop. Secretary Napolitano Applauds President Obama’s Intent to Nominate Grayling Williams as Director of the Office of Counternarcotics Enforcement.
The Office of what? Huh? How is it that I’ve been writing about drug policy for over 6 years and I missed an entire federal drug war bureaucracy? And it’s been around since 2004! Apparently they somehow coordinate “stopping the entry of illegal drugs into the U.S.”
So, how’s that going?
A couple of weeks ago, I noticed this article about medical marijuana and the workplace. It included this passage:
Clouding the issue even more is a decision earlier this month by the U.S. Justice Department not to pursue criminal charges against medical marijuana producers and users in states where it’s legal.
“That’s a very significant retreat from federal policy,” said Mark de Bernardo, executive director of the Institute for a Drug Free Workplace. “Marijuana is a dangerous drug that detrimentally affects the workplace. It has impacts on health care costs, productivity, accidents and employee turnover.”
I wrote a letter to Mr. de Bernardo, asking him for any data he had to support his claims, but he hasn’t responded. Surprise, surprise.
I’d still love to hear from you, Mark.